AIRS Overview

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance.

Wall Street analysts forecast AIRS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AIRS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

AirSculpt Technologies Inc revenue for the last quarter amounts to 39.39M USD, increased 0.05

AirSculpt Technologies Inc. EPS for the last quarter amounts to -0.03 USD, decreased -40.00

AirSculpt Technologies Inc (AIRS) has 330 emplpoyees as of May 10 2026.

Today AIRS has the market capitalization of 272.31M USD.